Drugmaker Novo Nordisk???s global program to improve diabetes care, DAWN (Diabetes Attitudes, Wishes and Needs)???originally launched in 2001 as a study???has thousands of participants from more than 30 countries, including primary care physicians, nurses, specialists and policy makers, in addition to diabetes patients and delegates from associations such as the World Health Organization.